BUDAPEST, HUNGARY, August 14, 2023/EINPresswire.com/ — VRG Therapeutics (VRG Tx), a pioneering biotechnology analysis and growth firm specializing in miniprotein-based prescribed drugs and mobile & gene remedy (CGT) merchandise, is happy to announce that it has efficiently secured a €5 million funding deal. The funding was led by the Budapest based mostly Széchenyi Funds (SZTA) with the participation of Vascular Group, the incumbent seed investor.
VRG Tx’s breakthrough particular person sequence enrichment sample (ISEP) platform harnesses the facility of directed evolution to create miniprotein-based therapeutics and CGT functions. This distinctive strategy attracts from the evolutionary conserved constructions of pure peptides and employs cutting-edge next-generation sequencing (NGS) analytics to design novel therapeutic candidates. These candidates supply unparalleled selectivity and affinity, combining some great benefits of each small molecules and biologics.
The funding, led by Széchenyi Funds, underscores its dedication to innovation. As a part of the funding, Széchenyi Funds will appoint members to VRG Tx’s new Board. This strategic collaboration positions VRG Tx for continued progress and growth. The funding allows VRG Tx to progress its pre-clinical drug candidate portfolio to IND enabling research in indications with main unmet medical wants together with migraine prophylaxis, central nervous system (CNS) issues, autoimmune illnesses and glioblastoma multiforme (GBM). Securing this funding gives a robust foundation for VRG Tx’s ongoing Series A fundraising efforts to advance its numerous portfolio of tasks.
About VRG Tx: VRG Therapeutics is an revolutionary biopharmaceutical R&D firm headquartered in Budapest, Hungary. VRG Tx is dedicated to leveraging its proprietary miniprotein ISEP know-how to sort out illnesses by way of mechanisms that typical biopharmaceutical approaches can’t obtain.
About Széchenyi Funds (SZTA): Széchenyi Funds is a serious Hungarian enterprise capital and personal fairness investor specializing in corporations with strong progress potential associated to Hungary and the CEE area. They handle € 400 million in belongings and 80+ portfolio corporations in a well-balanced portfolio representing a number of industries.
Zalan Peterfi
VRG Therapeutics
electronic mail us right here
Go to us on social media:
LinkedIn
Rajneesh Singh is a journalist at Asian News, specializing in entertainment, culture, international affairs, and financial technology. With a keen eye for the latest trends and developments, he delivers fresh, insightful perspectives to his audience. Rajneesh’s passion for storytelling and thorough reporting has established him as a trusted voice in the industry.
